Cargando…

Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward

PURPOSE: The cost-effectiveness of different guideline-concordant antimicrobial regimens for elderly patients with community-acquired pneumonia (CAP) was rarely discussed. This study attempts to explore the most appropriate cost-effectiveness of guideline-concordant antimicrobial regimen for elderly...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiudi, Chen, Liang, Wang, Yimin, Li, Hui, Wang, Hong, Xing, Xiqian, Zhang, Chunxiao, Suo, Lijun, Wang, Jinxiang, Yu, Guohua, Wang, Guangqiang, Yao, Xuexin, Yu, Hongxia, Wang, Lei, Liu, Xuedong, Cao, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140887/
https://www.ncbi.nlm.nih.gov/pubmed/34040398
http://dx.doi.org/10.2147/IDR.S302852
_version_ 1783696267323375616
author Han, Xiudi
Chen, Liang
Wang, Yimin
Li, Hui
Wang, Hong
Xing, Xiqian
Zhang, Chunxiao
Suo, Lijun
Wang, Jinxiang
Yu, Guohua
Wang, Guangqiang
Yao, Xuexin
Yu, Hongxia
Wang, Lei
Liu, Xuedong
Cao, Bin
author_facet Han, Xiudi
Chen, Liang
Wang, Yimin
Li, Hui
Wang, Hong
Xing, Xiqian
Zhang, Chunxiao
Suo, Lijun
Wang, Jinxiang
Yu, Guohua
Wang, Guangqiang
Yao, Xuexin
Yu, Hongxia
Wang, Lei
Liu, Xuedong
Cao, Bin
author_sort Han, Xiudi
collection PubMed
description PURPOSE: The cost-effectiveness of different guideline-concordant antimicrobial regimens for elderly patients with community-acquired pneumonia (CAP) was rarely discussed. This study attempts to explore the most appropriate cost-effectiveness of guideline-concordant antimicrobial regimen for elderly patients with CAP in general wards. PATIENTS AND METHODS: This was a multicenter, retrospective, 4:2:1 matched study enrolling 511 elderly patients with CAP hospitalized in general wards. Two hundred ninety-two patients prescribed with β-lactam monotherapy (group A), 146 patients prescribed with fluoroquinolone monotherapy (group B) and 73 patients prescribed with β-lactam/macrolide combination therapy (group C). Clinical outcomes and medical costs were analyzed by χ(2) test for categorical variables or Kruskal–Wallis H-test for continuous variables. RESULTS: There were no statistical differences in imaging features, etiology and complications during hospitalization among these three groups. The rates of clinical failure occurrence, in-hospital mortality, 30-day mortality and 60-day mortality also had no significant differences among group A, B and C patients; however, the median length of stay (LOS) in group A patients was 12.0 days, which was significantly higher than that in group B and C patients (both 10.0 days, p<0.02). The median total, drug, and antibiotic costs for one elderly CAP episode in group B patients were RMB 10368.4, RMB 3874.8, and RMB 1796.3, respectively, which were significantly lower than those in group A and C patients (p<0.01). CONCLUSION: Non-inferiority of clinical failure occurrence and short-term mortality was observed in different guideline-concordant antimicrobial regimens for elderly patients with CAP in general wards; however, the median LOS and hospitalization-associated costs for one elderly CAP episode with fluoroquinolone monotherapy were significantly lowest, and this strategy was considered to be the most cost-effective strategy in general wards.
format Online
Article
Text
id pubmed-8140887
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81408872021-05-25 Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward Han, Xiudi Chen, Liang Wang, Yimin Li, Hui Wang, Hong Xing, Xiqian Zhang, Chunxiao Suo, Lijun Wang, Jinxiang Yu, Guohua Wang, Guangqiang Yao, Xuexin Yu, Hongxia Wang, Lei Liu, Xuedong Cao, Bin Infect Drug Resist Original Research PURPOSE: The cost-effectiveness of different guideline-concordant antimicrobial regimens for elderly patients with community-acquired pneumonia (CAP) was rarely discussed. This study attempts to explore the most appropriate cost-effectiveness of guideline-concordant antimicrobial regimen for elderly patients with CAP in general wards. PATIENTS AND METHODS: This was a multicenter, retrospective, 4:2:1 matched study enrolling 511 elderly patients with CAP hospitalized in general wards. Two hundred ninety-two patients prescribed with β-lactam monotherapy (group A), 146 patients prescribed with fluoroquinolone monotherapy (group B) and 73 patients prescribed with β-lactam/macrolide combination therapy (group C). Clinical outcomes and medical costs were analyzed by χ(2) test for categorical variables or Kruskal–Wallis H-test for continuous variables. RESULTS: There were no statistical differences in imaging features, etiology and complications during hospitalization among these three groups. The rates of clinical failure occurrence, in-hospital mortality, 30-day mortality and 60-day mortality also had no significant differences among group A, B and C patients; however, the median length of stay (LOS) in group A patients was 12.0 days, which was significantly higher than that in group B and C patients (both 10.0 days, p<0.02). The median total, drug, and antibiotic costs for one elderly CAP episode in group B patients were RMB 10368.4, RMB 3874.8, and RMB 1796.3, respectively, which were significantly lower than those in group A and C patients (p<0.01). CONCLUSION: Non-inferiority of clinical failure occurrence and short-term mortality was observed in different guideline-concordant antimicrobial regimens for elderly patients with CAP in general wards; however, the median LOS and hospitalization-associated costs for one elderly CAP episode with fluoroquinolone monotherapy were significantly lowest, and this strategy was considered to be the most cost-effective strategy in general wards. Dove 2021-05-18 /pmc/articles/PMC8140887/ /pubmed/34040398 http://dx.doi.org/10.2147/IDR.S302852 Text en © 2021 Han et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Han, Xiudi
Chen, Liang
Wang, Yimin
Li, Hui
Wang, Hong
Xing, Xiqian
Zhang, Chunxiao
Suo, Lijun
Wang, Jinxiang
Yu, Guohua
Wang, Guangqiang
Yao, Xuexin
Yu, Hongxia
Wang, Lei
Liu, Xuedong
Cao, Bin
Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward
title Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward
title_full Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward
title_fullStr Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward
title_full_unstemmed Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward
title_short Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward
title_sort cost effectiveness of different initial antimicrobial regimens for elderly community-acquired pneumonia patients in general ward
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140887/
https://www.ncbi.nlm.nih.gov/pubmed/34040398
http://dx.doi.org/10.2147/IDR.S302852
work_keys_str_mv AT hanxiudi costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT chenliang costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT wangyimin costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT lihui costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT wanghong costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT xingxiqian costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT zhangchunxiao costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT suolijun costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT wangjinxiang costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT yuguohua costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT wangguangqiang costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT yaoxuexin costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT yuhongxia costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT wanglei costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT liuxuedong costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT caobin costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward
AT costeffectivenessofdifferentinitialantimicrobialregimensforelderlycommunityacquiredpneumoniapatientsingeneralward